-+ 0.00%
-+ 0.00%
-+ 0.00%

*Zenas BioPharma: Phase 2 MoonStone Trial in Relapsing Multiple Sclerosis Enrollment Concluding, Topline Results Expected Early in 4Q 2025 >ZBIO

Dow Jones·05/15/2025 11:08:00

Please log in to view news